Sign inJoin waitlistJoin the waitlist

Mohab Ibrahim

Program Director, Pain Medicine Fellowship · University of Arizona College of Medicine-Tucson

Credentials: · · · · · · ·

History

Pain Medicine Fellowship · University of Arizona College of Medicine-Tucson
Present
Pain Medicine Fellowship · University of Arizona College of Medicine-Tucson
Present
University of Arizona College of Medicine-Tucson
Present

Pain Medicine
Massachusetts General Hospital
2012–2013
Anesthesiology
Brigham and Women's Hospital
2009–2012
University of Arizona College of Medicine
2008–2009
University of Arizona
2004–2008
University of Arizona
2002
University of Arizona, 2004
1998

Research

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
Proceedings of the National Academy of Sciences of the United States of America · 2005 · First of 11 authors · 404 citations
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS
Proceedings of the National Academy of Sciences of the United States of America · 2003 · First of 11 authors · 382 citations
CB2 cannabinoid receptor-mediated peripheral antinociception
Pain · 2001 · 335 citations

Amol Patwardhan
29 papers · 1 as a fellow
Philip Malan
16 papers
RK
Rajesh Khanna
16 papers
VG
Vasudha Goel
13 papers
Hariharan Shankar
8 papers
Eellan Sivanesan
7 papers
Kevin Cheng
7 papers · 1 as a resident
Ratan Banik
6 papers
FP
Francis Porreca
4 papers
Julie Pilitsis
3 papers
Michelle Salloum
3 papers · 3 as a resident
Nathan Miller
3 papers

Grants

Identifying the Role of the Periaqueductal Gray in Mediating Traumatic Brain Injury Induced Thermal and Mechanical Hypersensitivity Reduction After Green Light Exposure
Department of Veterans Affairs · I01
Contact PI · Southern Arizona Va Health Care System
2023–2027
Developing Radiocaine NaV Imaging as a Response Monitoring Biomarker for Chronic Pain
National Institute of Neurological Disorders and Stroke · UG3
PI · $1.1M · Lutroo Imaging Llc
2023–2025
Repurposing Sulfasalazine in a Two-Arm Phase Two Double-Blind Randomized Clinical Trial for the Adjunct Management of Breast Cancer-Induced Bone Pain
National Cancer Institute · R21
Contact PI · $391.1K · University of Arizona
2021–2023
Green Light Therapy for Chronic Pain
National Center for Complementary and Integrative Health · R01
Contact PI · $2.1M · University of Arizona
2018–2023

Clinical trials

Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain
Principal investigator · Not yet recruiting
University of Arizona
2026–2029
Green Light Exposure in Healthy Volunteers Exposure in Normal Human Volunteers
Principal investigator · Active not recruiting
University of Arizona
2022–2026
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Principal investigator · Completed · Phase 2
University of Arizona
2021–2023
Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome
Principal investigator · Enrolling by invitation · Phase 2
University of Arizona
2021–2026